Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poliomyelitis inactivated vaccine injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
1 |
Inactivated poliovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Diphtheria/tetanus/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria + tetanus + inactivated poliovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
1 |
Diphtheria + tetanus + pertussis + inactivated poliovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Diphtheria/tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria (low dose)/ tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria (high dose)/ tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria, acellular pertussis, hepatitis B and inactivated polio vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
3 |
Diphtheria + tetanus + poliomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Diphtheria/tetanus/pertussis/poliomyelitis/Haemophilus influenzae b vaccine 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria + tetanus + pertussis + poliomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus + recombinant haemophilus influenzae type B vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
2 |
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
3 |
Diphtheria/tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
|
Diphtheria + acellular pertussis adsorbed + inactivated polio + tetanus toxoids vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
4 |
Administration of vaccine product containing only inactivated whole Human poliovirus antigen (procedure) |
Direct substance |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
4 |
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
1 |
Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
4 |
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Inactivated Poliovirus vaccine |
Inferred relationship |
Some |
5 |